Table 1 The characteristics of included patients
From: The deep vein thrombosis of lower limb after total hip arthroplasty: what should we care
Variables | DVT group(n = 36) | Non-DVT group(n = 146) | χ2/t | P |
|---|---|---|---|---|
Male/female | 20/16 | 92/54 | 1.046 | 0.102 |
Age(y) | 72.14 ± 8.02 | 68.11 ± 9.35 | 4.328 | 0.025 |
BMI(kg/m2) | 28.26 ± 4.55 | 26.02 ± 3.29 | 3.144 | 0.032 |
Diabetes | 19(52.78 %) | 25(17.12 %) | 1.118 | 0.009 |
Hypertension | 21(58.33 %) | 77(52.71 %) | 1.207 | 0.068 |
Hyperlipidemia | 10(27.78 %) | 42(28.77 %) | 1.084 | 0.106 |
Preoperative D-dimer (mg/L) | 0.69 ± 0.11 | 0.66 ± 0.12 | 1.230 | 0.074 |
Number of replacement joints | Â | Â | Â | Â |
Unilateral | 11(30.56 %) | 38(26.03 %) | 1.140 | 0.031 |
Bilateral | 25(69.44 %) | 108(73.97 %) | ||
Duration of surgery(min) | 133.62 ± 30.18 | 102 ± 27.42 | 9.124 | 0.015 |
Type of Anesthesia | Â | Â | Â | Â |
General anesthesia | 16(44.44 %) | 68(46.57 %) | 1.122 | 0.078 |
Epidural anesthesia | 20(55.56 %) | 78(53.42 %) | ||
Type of prosthesis | Â | Â | Â | Â |
Biological prosthesis | 6(16.67 %) | 72(49.32 %) | 1.205 | 0.036 |
Cemented prosthesis | 30(83.33 %) | 74(50.68 %) | ||
Duration of days in bed | 4.24 ± 1.22 | 2.79 ± 1.02 | 1.177 | 0.042 |
Anticoagulant drugs | Â | Â | Â | Â |
Rivaroxaban | 22(61.11 %) | 85(58.22 %) | 1.145 | 0.103 |
Low-molecular weight heparin calcium | 14(38.89 %) | 61(41.78 %) |